Skip to main content
Erschienen in: Journal of Inherited Metabolic Disease 6/2012

01.11.2012 | Original Article

Clinical variability of isovaleric acidemia in a genetically homogeneous population

verfasst von: M. Dercksen, M. Duran, L. IJlst, L. J. Mienie, C. J. Reinecke, J. P. N. Ruiter, H. R. Waterham, R. J. A. Wanders

Erschienen in: Journal of Inherited Metabolic Disease | Ausgabe 6/2012

Einloggen, um Zugang zu erhalten

Abstract

Isovaleric acidemia (IVA) is one of the most common organic acidemias found in South Africa. Since 1983, a significant number of IVA cases have been identified in approximately 20,000 Caucasian patients screened for metabolic defects. IVA is caused by an autosomal recessive deficiency of isovaleryl-CoA dehydrogenase (IVD) resulting in the accumulation of isovaleryl-CoA and its metabolites. In total, 10 IVA patients and three carriers were available for phenotypic and genotypic investigation in this study. All patients were found to be homozygous for a single c.367 G > A (p.G123R) mutation. The amino acid substitution of a glycine to arginine resulted in a markedly reduced steady-state level of the IVD protein, which explains the nearly complete lack of IVD enzyme activity as assessed in fibroblast homogenates. Despite the genetic homogeneity of this South African IVA group, the clinical presentation varied widely, ranging from severe mental handicap and multiple episodes of metabolic derangement to an asymptomatic state. The variation may be due to poor dietary intervention, delayed diagnosis or even epigenetic and polygenetic factors of unknown origin.
Literatur
Zurück zum Zitat Chalmers RA, Roe CR, Stacey TE, Hoppel CL (1984) Urinary excretion of L-carnitine and acylcarnitines by patients with disorders of organic acid metabolism: evidence for secondary insufficiency of L-carnitine. Pediatr Res 18:1325–1328PubMedCrossRef Chalmers RA, Roe CR, Stacey TE, Hoppel CL (1984) Urinary excretion of L-carnitine and acylcarnitines by patients with disorders of organic acid metabolism: evidence for secondary insufficiency of L-carnitine. Pediatr Res 18:1325–1328PubMedCrossRef
Zurück zum Zitat De Sousa C, Chalmers RA, Stacey TE, Tracey BM, Weaver CM, Bradley D (1986) The response to L-carnitine and glycine therapy in isovaleric acidaemia. Eur J Pediatr 144:451–456PubMedCrossRef De Sousa C, Chalmers RA, Stacey TE, Tracey BM, Weaver CM, Bradley D (1986) The response to L-carnitine and glycine therapy in isovaleric acidaemia. Eur J Pediatr 144:451–456PubMedCrossRef
Zurück zum Zitat Duran M, Van Sprang FJ, Drewes JG, Bruinvis L, Ketting D, Wadman SK (1979) Two sisters with isovaleric acidaemia, multiple attacks of ketoasidosis and normal development. Eur J Pediatr 131:205–211PubMedCrossRef Duran M, Van Sprang FJ, Drewes JG, Bruinvis L, Ketting D, Wadman SK (1979) Two sisters with isovaleric acidaemia, multiple attacks of ketoasidosis and normal development. Eur J Pediatr 131:205–211PubMedCrossRef
Zurück zum Zitat Duran M, Bruinvis L, Ketting D, Wadman SK, Van Pelt BC, Batenburg-Plenter AM (1982) Isovaleric acidaemia presenting with dwarfism, cataracts and congenital abnormalities. J Inher Metab Dis 5:125–127PubMedCrossRef Duran M, Bruinvis L, Ketting D, Wadman SK, Van Pelt BC, Batenburg-Plenter AM (1982) Isovaleric acidaemia presenting with dwarfism, cataracts and congenital abnormalities. J Inher Metab Dis 5:125–127PubMedCrossRef
Zurück zum Zitat Ensenauer R, Vockley J, Willard J et al (2004) A common mutation is associated with a mild, potentially asymptomatic phenotype in patients with isovaleric acidemia diagnosed by newborn screening. Am J Hum Genet 75:1136–1142PubMedCrossRef Ensenauer R, Vockley J, Willard J et al (2004) A common mutation is associated with a mild, potentially asymptomatic phenotype in patients with isovaleric acidemia diagnosed by newborn screening. Am J Hum Genet 75:1136–1142PubMedCrossRef
Zurück zum Zitat Erasmus C, Mienie L, Reinecke C, Wadman SK (1985) Organic aciduria in late-onset biotin-responsive multiple carboxylase deficiency. J Inher Metab Dis 8:105–106PubMedCrossRef Erasmus C, Mienie L, Reinecke C, Wadman SK (1985) Organic aciduria in late-onset biotin-responsive multiple carboxylase deficiency. J Inher Metab Dis 8:105–106PubMedCrossRef
Zurück zum Zitat Hoffmann GF, Feyh P (2002) Organic acid analysis. In: Blau N, Duran M, Blaskovics ME (eds) Physician’s guide to the laboratory diagnosis of metabolic diseases. Springer, Heidelberg, pp 27–44 Hoffmann GF, Feyh P (2002) Organic acid analysis. In: Blau N, Duran M, Blaskovics ME (eds) Physician’s guide to the laboratory diagnosis of metabolic diseases. Springer, Heidelberg, pp 27–44
Zurück zum Zitat Houten SM, Frenkel J, Rijkers GT, Wanders RJ, Kuis W, Waterham HR (2002) Temperature dependence of mutant mevalonate kinase activity as a pathogenic factor in hyper-IgD and periodic fever syndrome. Hum Mol Genet 11:3115–3124PubMedCrossRef Houten SM, Frenkel J, Rijkers GT, Wanders RJ, Kuis W, Waterham HR (2002) Temperature dependence of mutant mevalonate kinase activity as a pathogenic factor in hyper-IgD and periodic fever syndrome. Hum Mol Genet 11:3115–3124PubMedCrossRef
Zurück zum Zitat Ikeda Y, Dabrowski C, Tanaka K (1983) Separation and properties of five distinct acyl-CoA dehydrogenases from rat liver mitochondria. J Biol Chem 258:1066–1076PubMed Ikeda Y, Dabrowski C, Tanaka K (1983) Separation and properties of five distinct acyl-CoA dehydrogenases from rat liver mitochondria. J Biol Chem 258:1066–1076PubMed
Zurück zum Zitat Ikeda Y, Keese SA, Tanaka K (1985) Molecular heterogeneity of variant isovaleryl-CoA dehydrogenase from cultured isovaleric acidemia fibroblasts. Proc Nat Acad Sci USA 82:7081–7085PubMedCrossRef Ikeda Y, Keese SA, Tanaka K (1985) Molecular heterogeneity of variant isovaleryl-CoA dehydrogenase from cultured isovaleric acidemia fibroblasts. Proc Nat Acad Sci USA 82:7081–7085PubMedCrossRef
Zurück zum Zitat Krieger I, Tanaka K (1976) Therapeutic effects of glycine in isovaleric acidemia. Pediatr Res 10:25–29PubMedCrossRef Krieger I, Tanaka K (1976) Therapeutic effects of glycine in isovaleric acidemia. Pediatr Res 10:25–29PubMedCrossRef
Zurück zum Zitat Loots D, Erasmus E, Mienie LJ (2005) Identification of 19 new metabolites induced by normal amino acid conjugation in isovaleric acidemia. Clin Chem 51:1510–1512PubMedCrossRef Loots D, Erasmus E, Mienie LJ (2005) Identification of 19 new metabolites induced by normal amino acid conjugation in isovaleric acidemia. Clin Chem 51:1510–1512PubMedCrossRef
Zurück zum Zitat Mohsen AW, Anderson BD, Volchenboum SL et al (1998) Characterization of molecular defects in isovaleryl-CoA dehydrogenase in patients with isovaleric acidemia. Biochemistry 37:10325–10335PubMedCrossRef Mohsen AW, Anderson BD, Volchenboum SL et al (1998) Characterization of molecular defects in isovaleryl-CoA dehydrogenase in patients with isovaleric acidemia. Biochemistry 37:10325–10335PubMedCrossRef
Zurück zum Zitat Morava E, Steuerwald U, Carrozzo R et al (2009) Dystonia and deafness due to SUCLA2 defect; clinical course and biochemical markers in 16 children. Mitochondrion 9:438–442PubMedCrossRef Morava E, Steuerwald U, Carrozzo R et al (2009) Dystonia and deafness due to SUCLA2 defect; clinical course and biochemical markers in 16 children. Mitochondrion 9:438–442PubMedCrossRef
Zurück zum Zitat Mueller P, Schulze A, Schindler I, Ethofer T, Buehrdel P, Ceglareka U (2003) Validation of an ESI-MS/MS screening method for acylcarnitine profiling in urine specimens of neonates, children, adolescents and adults. Clin Chim Acta 327:47–57PubMedCrossRef Mueller P, Schulze A, Schindler I, Ethofer T, Buehrdel P, Ceglareka U (2003) Validation of an ESI-MS/MS screening method for acylcarnitine profiling in urine specimens of neonates, children, adolescents and adults. Clin Chim Acta 327:47–57PubMedCrossRef
Zurück zum Zitat Pitt JJ, Eggington M, Kahler SG (2002) Comprehensive screening of urine samples for inborn errors of metabolism by electrospray tandem mass spectrometry. Clin Chem 48:1970–1980PubMed Pitt JJ, Eggington M, Kahler SG (2002) Comprehensive screening of urine samples for inborn errors of metabolism by electrospray tandem mass spectrometry. Clin Chem 48:1970–1980PubMed
Zurück zum Zitat Reinecke C, Koekemoer G, Van der Westhuizen F et al (2011) Metabolomics of urinary organic acids in respiratory chain deficiencies in children. Metabolomics. doi:10.1007/s11306-011-0309-0 Reinecke C, Koekemoer G, Van der Westhuizen F et al (2011) Metabolomics of urinary organic acids in respiratory chain deficiencies in children. Metabolomics. doi:10.​1007/​s11306-011-0309-0
Zurück zum Zitat Shigematsu Y, Sudo M, Momoi T, Inoue Y, Susuki Y, Kameyama J (1982) Changing plasma and urinary organic acid levels in a patient with isovaleric acidemia during an attack. Pediatr Res 16:771–775PubMedCrossRef Shigematsu Y, Sudo M, Momoi T, Inoue Y, Susuki Y, Kameyama J (1982) Changing plasma and urinary organic acid levels in a patient with isovaleric acidemia during an attack. Pediatr Res 16:771–775PubMedCrossRef
Zurück zum Zitat Shih VE (2002) Amino acid analysis. In: Blau N, Duran M, Blaskovics ME (eds) Physician’s guide to the laboratory diagnosis of metabolic diseases. Springer, Heidelberg, pp 11–26 Shih VE (2002) Amino acid analysis. In: Blau N, Duran M, Blaskovics ME (eds) Physician’s guide to the laboratory diagnosis of metabolic diseases. Springer, Heidelberg, pp 11–26
Zurück zum Zitat Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD (1985) Measurement of protein using bicinchonic acid. Anal Biochem 1:76–85CrossRef Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD (1985) Measurement of protein using bicinchonic acid. Anal Biochem 1:76–85CrossRef
Zurück zum Zitat Strauss KA, Puffenberger EG (2009) Genetics, medicine and the plain people. Annu Rev GenomHum Gen 10:513–536CrossRef Strauss KA, Puffenberger EG (2009) Genetics, medicine and the plain people. Annu Rev GenomHum Gen 10:513–536CrossRef
Zurück zum Zitat Stumpf DA, Parker WD, Angelini C (1985) Carnitine deficiency, organic acidemias, and Reye’s syndrome. Neurology 35:1041–1045PubMedCrossRef Stumpf DA, Parker WD, Angelini C (1985) Carnitine deficiency, organic acidemias, and Reye’s syndrome. Neurology 35:1041–1045PubMedCrossRef
Zurück zum Zitat Sweetman L, Williams JC (2001) Branched chain organic acidemias. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular basis of inherited disease. McGraw-Hill, New York, pp 2125–2164 Sweetman L, Williams JC (2001) Branched chain organic acidemias. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular basis of inherited disease. McGraw-Hill, New York, pp 2125–2164
Zurück zum Zitat Tanaka K, Budd MA, Efron ML, Isselbacher KJ (1966) Isovaleric acidemia: a new genetic defect of the leucine metabolism. Proc Natl Acad Sci USA 56:236–242PubMedCrossRef Tanaka K, Budd MA, Efron ML, Isselbacher KJ (1966) Isovaleric acidemia: a new genetic defect of the leucine metabolism. Proc Natl Acad Sci USA 56:236–242PubMedCrossRef
Zurück zum Zitat Vatanavicharn N, Liammongkolkul S, Sakamoto O, Sathienkijkanchai A, Wasant P (2011) Phenotypic and mutation spectrums of Thai patients with isovaleric academia. Pediat Int 53:990–994CrossRef Vatanavicharn N, Liammongkolkul S, Sakamoto O, Sathienkijkanchai A, Wasant P (2011) Phenotypic and mutation spectrums of Thai patients with isovaleric academia. Pediat Int 53:990–994CrossRef
Zurück zum Zitat Vockley J, Ensenauer R (2006) Isovaleric acidemia: New aspects of genetic and phenotypic heterogeneity. Am J Med Genet Part C 142C:95–103PubMedCrossRef Vockley J, Ensenauer R (2006) Isovaleric acidemia: New aspects of genetic and phenotypic heterogeneity. Am J Med Genet Part C 142C:95–103PubMedCrossRef
Zurück zum Zitat Vockley J, Parimoo B, Tanaka K (1991) Molecular characteristics of four different classes of mutations in isovaleryl-CoA dehydrogenase gene responsible for isovaleric acidemia. Am J Hum Genet 49:147–157PubMed Vockley J, Parimoo B, Tanaka K (1991) Molecular characteristics of four different classes of mutations in isovaleryl-CoA dehydrogenase gene responsible for isovaleric acidemia. Am J Hum Genet 49:147–157PubMed
Zurück zum Zitat Vockley J, Rogan PK, Anderson BD et al (2000) Exon skipping in IVD RNA processing in isovaleric acidemia caused by point mutations in the coding region of the IVD gene. Am J Hum Genet 66:356–367PubMedCrossRef Vockley J, Rogan PK, Anderson BD et al (2000) Exon skipping in IVD RNA processing in isovaleric acidemia caused by point mutations in the coding region of the IVD gene. Am J Hum Genet 66:356–367PubMedCrossRef
Zurück zum Zitat Yudkoff M, Cohn RM, Puschak R, Rothman R, Segal S (1978) Glycine therapy in isovaleric acidemia. J Pediatr 92:813–817PubMedCrossRef Yudkoff M, Cohn RM, Puschak R, Rothman R, Segal S (1978) Glycine therapy in isovaleric acidemia. J Pediatr 92:813–817PubMedCrossRef
Metadaten
Titel
Clinical variability of isovaleric acidemia in a genetically homogeneous population
verfasst von
M. Dercksen
M. Duran
L. IJlst
L. J. Mienie
C. J. Reinecke
J. P. N. Ruiter
H. R. Waterham
R. J. A. Wanders
Publikationsdatum
01.11.2012
Verlag
Springer Netherlands
Erschienen in
Journal of Inherited Metabolic Disease / Ausgabe 6/2012
Print ISSN: 0141-8955
Elektronische ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-012-9457-2

Weitere Artikel der Ausgabe 6/2012

Journal of Inherited Metabolic Disease 6/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.